Popular Articles

200 Percent Increase In Cardiovascular Medication In Canada
A new study in the Canadian Medical Association Journal (CMAJ) reports that the number of prescriptions in Canada for cardiovascular medications has been increasing over the last ten years. There has been a 200 percent increase in costs. Overall costs of cardiovascular medications exceeded $5 billion in 2006. And statins accounted for nearly 40 percent of the expenditure.
generic viagra online
Heaviest Smokers Face Greatest Risk Of Death After Lung Cancer Diagnosis
It"s common knowledge that smoking raises risks of lung cancer. And yet researchers haven"t known whether continued smoking by lung cancer patients would increase the risk of the cancer"s spread.
News of the day
ZymoGenetics Reports Encouraging Phase 2 Results In Renal Cell Cancer For IL-21 With Nexavar(R)
ZymoGenetics, Inc. (NASDAQ:ZGEN) announced positive final results from a Phase 2 clinical trial in patients receiving 2nd or 3rd line therapy for advanced renal cell carcinoma with the combination of recombinant Interleukin 21 (IL-21) and Nexavar® (sorafenib) tablets. The combination demonstrated considerable clinical benefit, with an overall response rate (as assessed by an independent review) of 21%, a disease control rate of 82%, and progression-free survival (PFS) of 5.7 months in this heavily pretreated population. Results were presented at the American Society of Clinical Oncology meeting.
Health Insurance

PM&R Accepted For Abstracting And Indexing In MEDLINE

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that PM&R - The journal of injury, function and rehabilitation, the official scientific journal of the American Academy of Physical Medicine and Rehabilitation (AAPM&R), has been accepted for coverage by MEDLINE, just six months after its launch in January 2009. Under the guidance of Editor-in-Chief Stuart M. Weinstein, MD, Clinical Professor of Rehabilitation Medicine at the University of Washington, Seattle, and an internationally renowned Editorial Board, this monthly, peer-reviewed, scholarly publication has a clinical focus, presenting an array of topics pertinent to physiatrists (rehabilitation medicine physicians), to those in other related medical disciplines, as well as to a wider international readership. "It is particularly gratifying that a fledgling journal such as PM&R has already been recognized for its contribution to the advancement of physical medicine and rehabilitation," commented Dr. Weinstein. "Working in close partnership with the AAPM&R it is our goal to raise the scientific bar and build bridges between practitioners and researchers across this multidisciplinary field. I am thankful to the entire editorial and publishing team who have committed to the success of this journal." MEDLINE abstracting and indexing of PM&R will start as soon as possible and will be retroactive to Volume 1/Issue 1. MEDLINE is the U.S. National Library of Medicine"s premier bibliographic database containing over 16 million references to journal articles in life sciences with a concentration on biomedicine. PM&R was evaluated and selected for inclusion based on a stringent review process conducted by the Literature Selection Technical Review Committee, an NIH-chartered advisory committee of external experts. MEDLINE records of PM&R articles will also be accessible via PubMed®. "Rapid acceptance by MEDLINE clearly acknowledges the high-quality, significant work already published in PM&R and the continuing efforts of the highly-respected editors, reviewers and the Academy. We at Elsevier would like to thank them all for their contribution to this excellent achievement," stated Elsevier"s Herb Niemirow, Publisher of PM&R. Popularly known as the "Purple Journal," PM&R publishes articles that are contemporary and important to both clinical research and practice. The various sections of the journal highlight original research including clinical trials and observational studies, clinically relevant translational science, comprehensive and focused review articles, case presentations, point/counterpoint discussions and commentary, ethical-legal topics, practice management updates, topical study guides, editorial and opinion pieces, and clinical pearls. Continuing Medical Education opportunities for AMA PRA Category 1 Credit are also offered. PM&R coverage includes acute and chronic musculoskeletal disorders and pain, neurologic conditions involving the central and peripheral nervous systems, rehabilitation of impairments associated with disabilities in adults and children, and neurophysiology and electrodiagnosis. Herb Niemirow Elsevier Health Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):